semaglutide hair Study Offers More Evidence That Ozempic Could Cause Loss Wegovy, Ozempic Users Say Hair

(China) Boehringer Ingelheim International GmbH (Germany) Innovent (China) Sun Pharmaceutical Industries Ltd

This dual mechanism is why tirzepatide has produced greater weight loss in clinical trials than single-agonist GLP-1 drugs like semaglutide

Pros Cons Compounded version only available during FDA-confirmed shortages Compounded version must be drawn with syringe and injected manually Possible side effects: nausea, GI discomfort, headache, fatigue Not covered by insurance if compounded

This dose escalation drug has been extensively studied as a treatment strategy for managing obesity in individuals who do not have type 2 diabetes